Oxygenta Pharmaceutical Announces Key Leadership Resignations Amid Ownership Change
Oxygenta Pharmaceutical Limited, a subsidiary of Virupaksha Organics Limited, announced significant leadership changes. Managing Director and CFO Vankineni Sai Sudhakar and Independent Director Sanagari Kondal Reddy have resigned, effective August 18, 2025. Both cited the change in ownership and management as the reason for their departures. The company, known for its ISO certifications, made the disclosure in compliance with SEBI regulations. Executive Director Balasubba Reddy Mamilla signed the regulatory filing.
*this image is generated using AI for illustrative purposes only.
Oxygenta Pharmaceutical Limited, a subsidiary of Virupaksha Organics Limited, has announced significant changes in its top leadership following a change in ownership and management. The company, known for its ISO 9001:2015, ISO 14001:2018, and ISO 45001:2015 certifications, disclosed these developments in a regulatory filing to the BSE Limited.
Key Resignations
Vankineni Sai Sudhakar, who held the dual positions of Managing Director and Chief Financial Officer, has stepped down from both roles. Simultaneously, Sanagari Kondal Reddy has resigned from his position as an Independent Director. Both resignations are effective from August 18, 2025.
Reasons for Departure
According to the regulatory filing, both executives cited the change in ownership and management of the company as the primary reason for their resignations. In their respective resignation letters, both Sudhakar and Reddy confirmed that there were no other material reasons for their departures beyond the ownership transition.
Corporate Governance Compliance
The company's disclosure aligns with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. Oxygenta Pharmaceutical has provided detailed information as required under the SEBI Master Circular dated November 11, 2024.
Management's Response
Balasubba Reddy Mamilla, Executive Director of Oxygenta Pharmaceutical Limited, signed the regulatory filing on behalf of the company. The management has requested the BSE to take the resignations on record.
Company Profile
Oxygenta Pharmaceutical Limited, with its registered office and factory in Sangareddy District, Telangana, is a certified pharmaceutical company. The firm's corporate office is located in Hyderabad, and it operates under the CIN: L24110TG1990PLC012038.
As the company navigates this transition in leadership, stakeholders will be watching closely to see how these changes impact Oxygenta Pharmaceutical's future direction and performance in the pharmaceutical sector.
Historical Stock Returns for Oxygenta Pharmaceutical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.05% | -8.33% | -26.47% | +0.68% | +121.68% | +273.57% |
16
